Understand the source comparison
Comparison with Livagen
Livagen (Lys-Glu-Asp) shares structural similarity with Vilon but demonstrates 25-30% higher injection site reaction rates due to its larger molecular size.[93] Systemic side effects occur at similar frequencies, with Livagen showing marginally higher fatigue
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Livagen (Lys-Glu-Asp) shares structural similarity with Vilon but demonstrates 25-30% higher injection site reaction rates due to its larger molecular size.[93] Systemic side effects occur at similar frequencies, with Livagen showing marginally higher fatigue rates (12-18% vs. 10-15%).[94] Both peptides exhibit comparable safety profiles in animal studies up to 6 months duration.[95]